KIMBERLY-CLARK PROFESSIONAL
With the KIMTECH PURE* G3 Sterile STERLING* Nitrile Gloves, KIMBERLY-CLARK PROFESSIONAL* has introduced a low-cost sterile nitrile glove combining the sensitivity of latex with the protection of nitrile.
Engineered for Protection. Designed for Comfort.
KIMTECH PURE* G3 Sterile STERLING* Nitrile Gloves
KIMBERLY-CLARK PROFESSIONAL* has perfected a low-cost sterile nitrile glove combining the sensitivity of latex with the protection of nitrile. Our innovative STERLING* gloves manufacturing technology enables us to deliver a comfortable and affordable glove with all the protection and cleanliness our customers have come to expect.
When double-donned, the KIMTECH PURE* G3 Sterile STERLING* Nitrile Gloves deliver the equivalent feel & dexterity of a single latex glove without the risk of Type I latex allergic reactions. Protection has never been so comfortable.
The KIMTECH PURE* G3 Sterile STERLING* Nitrile Glove is also environmentally responsible. We have improved packaging to deliver 50% more gloves per case than traditional gloves. Average use of 25 cases per month results in reduction of 1 ton of waste per year vs. traditional latex gloves.
Quality standards
- PPE Category III product classified by EC Council Directive 89/686/EED
- Tested in accordance with EN Norms EN 420-2003
- Cleanroom packaged to meet the needs of Class 100 Cleanrooms
- Meets or exceeds AQL level of 1.5 for pinholes
- Manufactured in accordance with quality System ISO 9001
- Online Trend Data demonstrates product quality over time
For further information, please send an e-mail to Kimtech.support@kcc.com or visit www.contaminomics.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
